Baxter International Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名72/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價24.20。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Baxter International Inc評分
相關信息
行業排名
72 / 208
全市場排名
172 / 4582
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
18
分析師
持有
評級
24.201
目標均價
+33.26%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Baxter International Inc亮點
亮點風險
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
公司代碼BAX
公司Baxter International Inc
CEOHider (Andrew P)
網址https://www.baxter.com/
常見問題
Baxter International Inc(BAX)的當前股價是多少?
Baxter International Inc(BAX)的當前股價是 18.960。
Baxter International Inc 的股票代碼是什麼?
Baxter International Inc的股票代碼是BAX。
Baxter International Inc股票的52週最高點是多少?
Baxter International Inc股票的52週最高點是37.740。
Baxter International Inc股票的52週最低點是多少?
Baxter International Inc股票的52週最低點是17.400。
Baxter International Inc的市值是多少?
Baxter International Inc的市值是9.74B。
Baxter International Inc的淨利潤是多少?
Baxter International Inc的淨利潤為-649.00M。
現在Baxter International Inc(BAX)的股票是買入、持有還是賣出?
根據分析師評級,Baxter International Inc(BAX)的總體評級為持有,目標價格為24.201。
Baxter International Inc(BAX)股票的每股收益(EPS TTM)是多少
Baxter International Inc(BAX)股票的每股收益(EPS TTM)是-0.670。